The aims of this study were to assess the incidence rate and risk factors for sialorrhea in the long-term follow-up in a cohort of 132 patients with advanced Parkinson's disease [88 with deep brain stimulation (DBS) and 44 on medical treatment]. The incidence rate of sialorrhea did not differ between the two groups; male sex, Hoehn and Yahr stage and dysphagia resulted risk factors for sialorrhea. These findings indicate that DBS does not increase the risk of developing sialorrhea.
Bove, F., Genovese, D., Petracca, M., Tufo, T., Pisani, D., Lo Monaco, M. R., Bentivoglio, A. R., Calabresi, P., Piano, C., STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease, <<NPJ PARKINSON'S DISEASE>>, 2022; 8 (1): N/A-N/A. [doi:10.1038/s41531-022-00348-1] [https://hdl.handle.net/10807/235234]
STN-DBS does not increase the risk of sialorrhea in patients with advanced Parkinson's disease
Bove, Francesco;Petracca, Martina;Tufo, Tommaso;Lo Monaco, Maria Rita;Bentivoglio, Anna Rita;Calabresi, Paolo;Piano, Carla
2022
Abstract
The aims of this study were to assess the incidence rate and risk factors for sialorrhea in the long-term follow-up in a cohort of 132 patients with advanced Parkinson's disease [88 with deep brain stimulation (DBS) and 44 on medical treatment]. The incidence rate of sialorrhea did not differ between the two groups; male sex, Hoehn and Yahr stage and dysphagia resulted risk factors for sialorrhea. These findings indicate that DBS does not increase the risk of developing sialorrhea.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
